Versant Venture Capital VI, L.P. - 10%+ Owner at Black Diamond Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
BDTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Versant Venture Capital VI, L.P. - trading volume in the past year for Black Diamond Therapeutics, Inc.

Holdings reported by Versant Venture Capital VI, L.P. for Black Diamond Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.73M $23.6M $6.32 Aug 28, 2024 Direct
Common Stock 822K $5.2M $6.32 Aug 28, 2024 Indirect

Transactions reported by Versant Venture Capital VI, L.P. for Black Diamond Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.